Document is current
Any future updates will be listed below
-
Authors
Brugulat-Serrat, Anna
Sánchez-Benavides, Gonzalo
Cacciaglia, Raffaele
Salvadó, Gemma
Shekari, Mahnaz
Collij, Lyduine E.
Buckley, Christopher
van Berckel, Bart N. M.
Perissinotti, Andrés
Niñerola-Baizán, Aida
Milà-Alomà, Marta
Vilor-Tejedor, Natàlia
Operto, Grégory
Falcon, Carles
Grau-Rivera, Oriol
Arenaza-Urquijo, Eider M.
Minguillón, Carolina
Fauria, Karine
Molinuevo, José Luis
Suárez-Calvet, Marc
Gispert, Juan Domingo https://orcid.org/0000-0002-6155-0642
,
Cañas, Alba
Canals, Lidia
Iglesias, Laura
Marne, Paula
Beteta, Annabella
Deulofeu, Carme
Emilio, Maria
Cumplido, Irene
Domínguez, Ruth
Fuentes, Sherezade
Hernández, Laura
Vilanova, Marc
Solsona, Lluís
Huesa, Gema
Huguet, Jordi
Menchón, Tania
Polo, Albina
Pradas, Sandra
Sala-Vila, Aleix
Soteras, Anna
Stankeviciute, Laura
Akinci, Müge
Palpatzis, Eleni
Genius, Patricia
Rodríguez, Blanca
García, Marina
Ortiz-Romero, Paula
-
Funding
Funding for this research was provided by:
Juan de la Cierva (FJC2018- 038085-I)
La Caixa (LCF/PR/GN17/10300004, 100010434)
Health Department of the Catalan Government (SLT002/16/00201)
Ministerio de Ciencia, Innovación y Universidades (IJC2020-043417-I)
Alzheimer's Association (2019-AARF-644568, AARG 2019-AARG-644641, AARG 2019-AARG-644641-RAPID)
Ramón y Cajal (RYC2018-026053-I, RYC-2013-13054)
Spanish Ministry of Science and Innovation (PID2019-111514RA-I00)
European Union’s Horizon 2020 (European Union’s Horizon 2020)
Instituto de Salud Carlos III (PI19/00155)
H2020 European Institute of Innovation and Technology (LCF/BQ/PR21/11840004)
- License Information
-
More Information
Article History
Received: 25 August 2022
Accepted: 10 February 2023
First Online: 1 March 2023
Declarations
:
: The ALFA parent cohort and the ALFA+ studies were approved by an independent Ethics Committee Parc de Salut Mar Barcelona (Spain) and registered at Clinicaltrials.gov (Identifiers: NCT01835717 and NCT02485730, respectively). All participants signed the study’s informed consent form that had also been approved by the Independent Ethics Committee “Parc de Salut Mar”, Barcelona. A statement to confirm that all methods were carried out in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Not applicable.
: AB-S, GS-B, RC, GS, MS, LEC, AN-B, MM-A, NV-T, GO, CF, OG-R, EMA-U, CM, KF, and JDG report no existing potential conflicts of interest relevant to this article. BvB has received research support from EU-FP7, CTMM, ZonMw, NWO, and Alzheimer Nederland. BvB has performed contract research for Rodin, IONIS, AVID, Eli Lilly, UCB, DIAN-TUI, and Janssen. BvB was a speaker at a symposium organized by Springer Healthcare. BvB has a consultancy agreement with IXICO for the reading of PET scans. BvB is a trainer for GE. BvB only receives financial compensation from Amsterdam UMC. MS-C has served as a consultant and at advisory boards for Roche Diagnostics International Ltd and has given lectures in symposia sponsored by Roche Diagnostics, S.L.U and Roche Farma, S.A. JLM is currently a full-time employee of H. Lundbeck A/S and previously has served as a consultant or on advisory boards for the following for-profit companies or has given lectures in symposia sponsored by the following for-profit companies: Roche Diagnostics, Genentech, Novartis, Lundbeck, Oryzon, Biogen, Lilly, Janssen, Green Valley, MSD, Eisai, Alector, BioCross, GE Healthcare, and ProMIS Neurosciences.
